CASI Pharmaceuticals CASIF
OTC CASIF
$0.12 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Non Operating Investment Income (2023 - 2025)

Updated

CASI Pharmaceuticals (CASIF) reported Non Operating Investment Income of -$179 billion for FY2025, compared with -$1.7 trillion in FY2024.

Analysis

CASI Pharmaceuticals (CASIF) Non Operating Investment Income (2023 - 2025) Analysis & Trends

Dating back to FY2020, CASI Pharmaceuticals' Non Operating Investment Income record includes 6 years.

  • The FY2025 figure ranks as the highest annual Non Operating Investment Income since FY2022.
  • According to Business Quant data, Non Operating Investment Income came in at -$1.7 trillion in FY2024, -$581 billion in FY2023, -$8.9 million in FY2022 and -$5.66 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 CASI Pharmaceuticals 2.47 Mn -18.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -269,000.00
Dec 31, 2024 -1,696.00 Bn
Jun 30, 2024 500,000.00
Mar 31, 2024 -171,000.00
Mar 31, 2023 -140,000.00
API Access

CASI Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CASIF&period=max&api_key=YOUR_API_KEY